Clinical trials recruiting for Third-line and Beyond Therapy
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Administration of Vorolanib | 1 |
| Trifluridine/tipiracil (TAS-102) plus bevacizumab | 1 |
Self-screener
Recruiting trials
- Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
- Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Related conditions
Trials recruiting for Third-line and Beyond Therapy often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Colorectal cancer 1359Colo-rectal Cancer 26Bevacizumab 3Advanced Non-small Cell Lung Cancer (NSCLC) 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Third-line and Beyond Therapy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.